<REFS>1. Hoffmann JL. Congenital Heart Disease: Incidence and Inheritance. Pediatr

Total Page:16

File Type:pdf, Size:1020Kb

<REFS>1. Hoffmann JL. Congenital Heart Disease: Incidence and Inheritance. Pediatr

References.

1. Hoffmann JL. Congenital heart disease: incidence and inheritance. Pediatr Clin

North Am 1990;37:25–30.

2. Reller M, Strickland MJ, Riehle-Colarusso T, et al. Prevalence of congenital heart

defects in metropolitan Atlanta, 1998–2005. J Pediatr 2008;153:807–13.

3. Pradat P, Franeannet C, Harris JA, et al. The epidemiology of cardiovascular

defects – Part I: a study based on data from three large registries of congenital

malformations. Pediatr Cardiol 2003;24:195–221.

4. Schultz AH, Localio AR, Clark BJ, et al. Epidemiologic features of the

presentation of critical congenital heart disease: implications for screening.

Pediatrics 2008;121:751–9.

5. McElhinney DB, Marshall AC, Wilkins-Haug LE, et al. Predictors of technical

success and postnatal biventricular outcome after in-utero aortic valvuloplasty for

aortic stenosis with evolving hypoplastic left heart syndrome. Circulation

2009;120:1482–90.

6. Bacha EA, Hijazi ZM, Cao QL, et al. Hybrid pediatric cardiac surgery. Pediatr

Cardiol 2005;26:315–22.

7. Chen Q, Parry AJ, The current role of hybrid procedures in the stage 1 palliation of

patients with hypoplastic left heart syndrome. Eur J Cardiothorac Surg

2009;36:77–83.

8. Roger LV, Go AS, Lloyd-Jones DM, et al. Heart Disease and stroke statistics –

2012 update: a report from the American Heart Association. Circulation

2012;125:e97–e102. 9. Go As, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics – 2013

update: a report from the American Heart Association. Circulation 2013;127:e153–

9.

10. Franck LS, Spencer C. Informing parents about anesthesia for children’s surgery: a

critical literature review. Patient Education and Counseling 2005;59:117–25.

11. Li HCW, Lopez V, Lee TLI. Psycho-educational preparation of children for

surgery: the importance of parental involvement. Patient Educ Couns 2007;65:34–

41.

12. Empey DW, Laitinen LA, Jacobs L, Gold WM, Nadel JA. Mechanisms of

bronchial hyper-reactivity in normal subjects after upper respiratory tract infection.

Am Rev Respir Dis 1976;113:131–9.

13. Tait AR, Malviya S. Anesthesia for the child with an upper respiratory tract

infection: still a dilemma? Anesth Analg 2005;100:59–65. .

14. Parnis SJ, Barker DS, Van Der Walk JH. Clinical predictors of anaesthetic

complications in children with respiratory tract infections.

PediatrAnesth;2011;11:29–40.

15. Malviya S, Voepel-Lewis T, Siewert M, et al. Risk factors for adverse

postoperative outcomes in children presenting for cardiac surgery with upper

respiratory tract infections. Anesthesiology;2003:98:628–32.

16. Park MK. Manifestations of cardiac problems in newborns: cyanosis in newborns.

In: Park MK (ed.) Pediatric cardiology for practitioners, 4th edn. St. Louis: Mosby,

2002, pp. 374–75.

17. Bernstein D. Evaluation of the cardiovascular system: history of physical

examination. In: Behrman RE (ed.) Nelson textbook of pediatrics, 17th edn.

Philadelphia: WB Saunders, 2004, pp. 1481–88. 18. Jhang WK, Park JJ, Seo DM, Goo HW, Gwak M. Perioperative evaluation of

airways in patients with arch obstruction and intracardiac defects. Ann Thorac Surg

2008 85:1753–58.

19. Heinrich S, Birkholz T, Ihmsen H, Irouschek A, Ackermann A, Schmidt J.

Incidence and predictors of difficult laryngoscopy in 11,219 pediatric anesthesia

procedures. Pediatr Anesth;2012;22:729–36.

20. Litman RS, Zernqast BA, Perkins FM. Preoperative evaluation of the cervical

spine in children with Trisomy 21: results of a questionnaire study. Pediatr Anesth

1995;5:355–361.

21. Brockmeyer D. Down Syndrome and Craniovertebral instability. Pediatr

Neurosurg 1999;31:71–77 .

22. Cormack RS: Cormack-Lehane classification revisited. Br J Anaesth

2010;105:867–8.

23. Heinrich S, Birkholz T, Ihmsen H, et al. Incidence and predictors of poor

laryngoscopic view in children undergoing pediatric cardiac surgery. J

Cardiothorac Vasc Anesth 2013;27:516–21.

24. Tennstedt C, Chaoui R, Korner H, and Dietel M. Spectrum of congenital heart

disease defects and extracardiac malformations associated with chromosomal

abnormalities: results of as seven year necroscopy study. Heart;1999;82:34–9.

25. Richardson P, McKenna W, Bristow Met al. Report of the 1995 World Health

Organization/International Society and Federation of Definition and Classification

of cardiomyopathies. Circulation;1996;93:841–2.

26. Ross RD: The Ross Classification for Heart Failure in Children after 25 years: a

review and age-stratified revision. Pediatr Cardiol 2012;33:1295–300. 27. Kantor PF, Lougheed J, Dancea A, et al. Presentation, diagnosis, and medical

management of heart failure in children: Canadian Cardiovascular Society

Guidelines. Can J Cardiol 2013;29:1535–52.

28. Rossano JW, Kim JJ, Decker JA, et al. Prevalence, morbidity and mortality of

heart failure-related hospitalizations in children in the United States: a population

based study. J Cardiac Fail 2012;18:459–70.

29. Atz AM, Colan SD, Pasquali SK, et al. Investigators. Factors associated with serum

brain natriuretic peptide levels after the Fontan procedure. Cong Heart Dis

2011;6:313–21.

30. Hopkins WE, Chen Z, Fukagawa NK, et al. Increased atrial and brain natriuretic

peptides in adults with cyanotic congenital heart disease: enhanced understanding

of the relationship between hypoxia and natriuretic peptide secretion. Circulation

2004;109:2872–7.

31. Carmosino MJ, Friesen R, Doran A, et al. Perioperative complications in children

with pulmonary hypertension undergoing noncardiac surgery or cardiac

catheterization. Anesth Analg 2007;104:521–527.

32. Hill KD, Lim S, Everett A, et al. Assessment of pulmonary hypertension in the

pediatric catheterization laboratory: current insights from the MAGIC Registry.

Cath Cardiovasc Interventions 2010;76:865–873.

33. Friesen RH, Williams GD. Anesthetic management of children with pulmonary

arterial hypertension. Pediatr Anesth 2008;18:208–216. .

34. Mahle WT, Newburger JW, Matherne GP, et al. Role of pulse oximetry in

examining newborns for congenital heart disease: A Scientific Statement from the

American Heart Association and American Academy of Pediatrics. Circulation

2009;120:447–458 . 35. Cnota JF, Gupta R, Michelfelder EC, et al. Congenital heart disease infant death

rates decrease as gestational age advances from 34–40 weeks. J Pediatr

2011;159:761–765.

36. Goff DA, Luan X, Gerdes M, et al. Younger gestational age is associated with

worse neurodevelopmental outcomes after cardiac surgery in infancy. J Thorac

Cardiovasc Surg 2012;143:535–542.

37. Morris SA, Ethen MK, Penny DJ, et al. Prenatal diagnosis, birth location, surgical

center, and neonatal mortality in infants with hypoplastic left heart syndrome.

Circulation 2014;129:285–292. .

38. Sochet AA, Ayers M, Quezada E, et al. The importance of small for gestational age

in the risk assessment of infants with critical congenital heart disease. Cardiol

Young 2013;23:896–904.

39. Hickey EJ, Nosikova Y, Zhang H, et al. Very low birth weight infants with

congenital cardiac lesions: is there merit in delaying intervention to permit growth

and maturation? J Thorac Cardiovasc Surg 2012;143:126–136.

40. Oh YI, Lee JH, Nam SB, et al. Effects of chronic angiotensin II receptor

antagonists and angiotensin-converting enzyme inhibitor treatment on

neurohormonal levels and hemodynamics during cardiopulmonary bypass. Br J

Anaesth 2006;97:792–798.

41. Morrison J, Killip T. Serum digitalis and arrhythmia in patients undergoing

cardiopulmonary bypass. Circulation;1973;47:341–52.

42. Krasula R, Hastreiter A, Levitsyl S. Serum, atrial, and urinary digoxin levels

during cardiopulmonary bypass in children. Circulation;1974;49:1047–52.

43. Monagle P, Chalmers E, Chan A, DeVeber G, Kirkham F, Massicotte P, Michelson

AD; et al. American College of Chest Physicians. Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based

Clinical Practice Guidelines (8th Edition). Chest 2008:133(6 Suppl):887S-–968S. .

44. Israels SJ, Michelson AD. Antiplatelet therapy in children. Thromb

Res;2006;118:75–83.

45. Hylek EM, Regan S, Go AS, Hughes RA, Singer DE, Skates SJ.et al. Clinical

predictors of prolonged delay in return of the international normalized ratio to

within the therapeutic range after excessive anticoagulation with warfarin. Ann

Intern Med;2001;135:393. .

46. Levine MN, Raskob G, Landefeld S, Hirsh J. Hemorrhagic complications of

anticoagulant treatment; Chest 1995:108(4 Suppl):276S.

47. Navaratnam M, Dubin A. Pediatric pacemakers and ICD’s: how to optimize

perioperative care. Pediatr Anesth 2011;21:512–521.

48. Berul CI, VanHare GF, Kertesz ML, et al. Results of a multicenter retrospective

implantable cardioverter-defibrillator registry of pediatric and congenital heart

disease patients. J Am Coll Cardiol 2008;51:1685–1691.

49. Zaidan JR, Atlee JL, Belott P, et al. Practice Advisory for the perioperative

management of patients with cardiac rhythm management devices: pacemakers and

implantable cardioverter-defibrillators: a report by the American Society of

Anesthesiologists Task Force on Perioperative Management of Patients with

Cardiac Rhythm Management Devices. Anesthesiology 2005;103:186–198.

50. Schulman PM, Rozner MA. Use caution when applying magnets to pacemakers or

defibrillators for surgery. Anesth Analg 2013;117:422–427.

51. Kontras SB, Bodenbender JG, Craenen J, Hosier DM. Hyperviscosity in congenital

heart disease. J Pediatr;1970;76:214–20. 52. Perloff, JK, Rosove MH, Sietsema KE. Cyanotic congenital heart disease: a

multisystem disorder. In: Perloff JK, Child JS (eds). Congenital Heart Disease in

Adults, 2nd ednition. Saunders, Philadelphia: Saunders, 1998, pp. 199–226.. .

53. White R, Moffit E, Feldt R, Ritter DG. Myocardial metabolism in cyanotic

congenital heart disease. Anesth Analg 1972;51:6–10.

54. Committee on Genetics: “Health supervision for children with Down syndrome."..

Pediatrics 2011;128 :393–406 .

55. Lopes AA, Barst RJ, Haworth SG, et al. Repair of congenital heart disease with

associated pulmonary hypertension in children: what are the minimal investigative

procedures? Consensus statement from the Congenital Heart Disease and Pediatric

Task Forces, Pulmonary Vascular Research Institute (PVRI). Pulm Circ

2014;4:330–341.

56. Krishnamurthy R, Chitkara P, Congenital Heart Disease. In: Medina SL,

Blackmore CC, Applegate KE (, eds. ) Evidence Based Imaging in Pediatrics (1st

edition). Springer, New York: Springer, 2010.

57. Mossad E, Farid I, Youssef G, et al. Diverticulum of Kommerell: a review of a

series and a report of a case with tracheal deviation compromising single lung

ventilation. Anesth Analg 2002;94:1462–1464.

58. Nishi H, Mitsuno M, Yamamura M, et al. Safe approach for redo coronary artery

bypass grafting-preventing injury to the patent graft to the left anterior descending

artery. Ann Thorac Surg 2010;16:253–258.

59. Raval NC, Gonzalez E, Bhat AM, et al. Umbilical venous catheters: evaluation of

radiographs to determine position and associated complications of malpositioned

umbilical venous catheters. Am J Perinatol 1995;12:201–204. 60. Butt WW, Whyte H. Blood pressure monitoring in neonates: comparison of

umbilical and peripheral artery catheter measurements. J Pediatr 1984;105:630–

632.

61. Fonseca B, Chang RK, Senac M, et al. Chest Radiography radiography and the

evaluation of the neonate with congenital heart disease. Pediatr Cardiol

2005;26:367–372.

62. Wellen SL, Glatz AC, Gillespie MJ, et al. Usefulness of transthoracic

echocardiography to accurately diagnose recoarctation of the aorta after the

Norwood procedure. Am J Cardiol 2014;114:117–121.

63. Bruch C, Klem I, Breithardt G, et al. Diagnostic usefulness and prognostic

implications of the mitral E/E’ ratio in patients with heart failure and severe

secondary mitral regurgitation. Am J Cardiol 2007;100:860–865.

64. DeOliveira NC, Sittiwangkul R, McCrindle BW, et al. Biventricular repair in

children with atrioventricualr septal defects and a small right ventricle: anatomic

and surgical considerations. J Thorac Cardiovasc Surg 2005;130:250–257.

65. Silverman NH. Echocardiographic Anatomy. In: Silverman NH (Eded.) Pediatric

Echocardiographyechocardiography. Williams & Wilkins, Baltimore, MD, :

Williams & Wilkins, 1993, pp. 1–34.

66. Adriaanse BM, Tromp CHN, Simpson JM, et al. Interobserver agreement in

detailed prenatal diagnosis of congenital heart disease by telemedicine using four-

dimensional ultrasound with spatiotemporal image correlation. Ultrasound Obstet

Gynecol 2012;39:203–209.

67. Dragulescu A, Mertens L, Friedberg MK. Interpretation of left ventricular diastolic

dysfunction in children with cardiomyopathy by echocardiography: problems and

limitations. Circ Cardiovasc Imaging 2013;6:254–261. 68. Saleeb SF, Margossian R, Spencer CT, et al. Reproducibility of echocardiographic

diagnosis of left ventricular noncompaction. J Am Soc Echocardiog 2012;25:194–

202.

69. Brown DW, Gauvreau K, Powell AJ, Lang P, Colan SD, Del Nido PJ, Odegard

KC, Geva T.et al. Cardiac magnetic resonance versus routine cardiac

catheterization before bidirectional Glenn anastomosis in infants with functional

single ventricle: a prospective randomized trial. Circulation 2007;116:2718–25.

70. Stern KW, McElhinney DB, Gauvreau K, et al. Echocardiographic evaluation

before bidirectional Glenn operation in functional single-ventricle heart disease:

comparison to cathater aniography. Circ Cardiovasc Imaging 2011;4:498–505.

71. Hill KD, Lim DS, Everett AD, et al. Assessment of pulmonary hypertension in the

pediatric cathaterization laboratory: current insights from the Magic registry.

Catheter Cardiovasc Interv 2010;76:865–873.

72. Bridges ND, O'Laughlin MP, Mullins CE, Freed MD. Cardiac catheterization,

angiography, and intervention. In: Allen HD, Gutgesell HP, Clark EB, Driscoll DJ

(Edseds.) Moss and Adams' Heart Disease in Infants, Children, and Adolescents,

6th Ednedn. Lippincott Williams & Wilkins , Philadelphia: Lippincott Williams &

Wilkins, 2001. , pp. 276–324.

73. Krishnamurthy R, Chung T. Current imaging status: pediatric cardiac MRI. In

Lucaya J, Strife JL (eds) Eds. Pediatric Chest Imaging. , 2nd edition. Berlin:

Springer Publishers, Berlin, 2007.

74. Valente AM, Cook S, Festa P, Ko HH, Krishnamurthy R, Taylor AM, et al.

Multimodality imaging guidelines for patients with repaired tetralogy of fallot: a

report from the American society Society of Echocardiography: developed in collaboration with the society for cardiovascular magnetic resonance and the

society for pediatric radiology. J Am Soc Echocardiogr. 2014;27:111–41.

75. Fogel MA. Is routine cardiac catheterization necessary in the management of

patients with single ventricles across staged Fontan reconstruction? No! Pediatr

Cardiol. 2005 Mar-Apr;26:154–8. .

76. Sena L, Krishnamurthy R, Chung T. Pediatric cardiac CT. In: Lucaya J, Strife JL

(eds. ) Pediatric Chest Imaging. , 2nd edn. Berlin: Springer Publishers, Berlin,

2007.

77. An HS, Choi EY, Kwon BS, Kim GB, Bae EJ, Noh CI, et al. Airway compression

in children with congenital heart disease evaluated using computed tomography.

Ann Thorac Surg. 2013;96:2192–7.

78. Han BK, Lesser AM, Vezmar M, Rosenthal K, Rutten-Ramos S, Lindberg JJ et al.

Cardiovascular imaging trends in congenital heart disease: a single center

experience. Cardiovasc Comput Tomogr. 2013;7:361–6.

79. Tuo G, Khambadkone S, Tann O, et al. Obstructive left heart disease in neonates

with a “borderline” left ventricle: diagnostic challenges to choosing the best

outcome. Pediatr Cardiol 2013;34:1567–1576.

80. Grosse-Wortmann L, Yun TJ, Al-Radi O, et al. Borderline hypoplasia of the left

ventricle in neonates: insights for decision-making from functional assessment with

magnetic resonance imaging. J Thorac Cardiovasc Surg 2008;136:1429–1436.

81. Rios DR, Welty SE, Gunn JK, et al. Usefulness of routine head ultrasound scans

before surgery for congenital heart disease. Pediatrics 2013;131:e1765-–e1770.

82. Andropoulos DB, Ahmad HB, Haq T, et al. The association between brain injury,

perioperative anesthetic exposure, and 12-month neurodevelopmental outcomes after neonatal cardiac surgery: a retrospective cohort study. Pediatr Anesth

2014;24:266–274.

83. Block AJ, Mcquillen PS, Chau V, et al. Clinically silent preoperative brain injuries

do not worsen with surgery in neonates with congenital heart disease. J Thorac

Cardiovasc Surg 2010;140:550–557.

84. Practice guidelines for preoperative fasting and the use of pharmacologic agents to

reduce the risk of pulmonary aspiration: application to healthy patients undergoing

elective procedures: an updated report by the American Society of

Anesthesiologists Committee on Standards and Practice Parameters.

Anesthesiology 2011;114:495–511. .

85. Cook-Sather SD, Litman RS. Modern fasting guidelines in children. Best practice

and research. Clinical Anesthesiology;2006:20:471–481. .

86. Nicolson SC, Dorsey AT, Schreiner MS. Shortened preanesthetic fasting interval in

pediatric cardiac surgical patients. Anesth Analg;1992;74:694–7.

87. Castillo-Zamora C, Castillo-Peralta LA, Nava-Ocampo A. Randomized trial

comparing overnight preoperative fasting period vs. oral administration of apple

juice at 6:00–6:30 AM in pediatric orthopedic surgical patients. Pediatr Anesth

2005:15:638–42. .

88. Kain ZN, Mayes LC, O'Connor TZ, Cicchetti DV. Preoperative anxiety in children.

predictors and outcomes. Arch Pediatr Adolesc Med 1996;150:1238–45.

89. McMillan CO, Spahr-Schopfer IA, Sikich N, Hartley E, Lerman J. Premedication

of children with oral midazolam . Can J Anesth;1992;39:545–50.

90. Malinovsky JM, Populaire C, Cozian A, et al.Lepage JY, Lejus C, Pinaud M.

Premedication with midazolam in children. Effect of intranasal, rectal and oral

routes on plasma midazolam concentrations. Anaesthesia 1995; Apr;50:351–4. 91. Talon MD1, Woodson LC, Sherwood ER, et al.Aarsland A, McRae L, Benham T.

Intranasal dexmedetomidine premedication is comparable with midazolam in burn

children undergoing reconstructive surgery. J Burn Care Res 2009;30:599–605.

92. Rushani D, Kaufman JS, Ionescu-Ittu R, et al. Infective endocarditis in children

with congenital heart disease: cumulative incidence and predictors. Circulation

2013;128:1412–1419.

93. Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis.

Guidelines From the American Heart Association: A Guideline From the American

Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease

Committee, Council on Cardiovascular Disease in the Young, and the Council on

Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the

Quality of Care and Outcomes Research Interdisciplinary Working Group.

Circulation 2007;116:1736–1754.

94. Frimpong-Boateng K, Amoah AGB, Barwasser HM.Cardiopulmonary bypass in

sickle cell anaemia without exchange transfusion. Eur J Cardiothorac Surg

1998;14:527–9.

95. Metras D, Coulibaly AO, Quattara K. Open heart surgery in sickle cell

hemoglobinopathies: report of 15 cases. Thorax 1982;37:486–91.

96. Vichinsky EP, Haberkern CM, Neumayr L. A comparison of conservative and

aggressive transfusion regimens in the perioperative management of sickle cell

disease. The Perioperative Transfusion in Sickle Cell Disease Study Group. New

Eng J Med 1995;333:206–13. 97. Sanders DB, Smith BP, Sowell SR, et al. Sickle cell disease and complex

congenital cardiac surgery: a case report and review of the pathophysiology and

perioperative management. Perfusion 2014;29:153–158.

98. Ramamoorthy C, Haberkern C, Bhananker S, et al.Domino K, Posner K, Campos J,

and Morray J. Anesthesia-related cardiac arrest in children with heart disease: data

from the Pediatric Perioperative Cardiac Arrest (POCA) registry. Anesth Analg

2010;110:1376–82. .

99. Baum V, Barton D, and Howard Gutgesell. Influence of congenital heart disease on

mortality after non-cardiac surgery in hospitalized children. Pediatrics

2000;105:332–335.

100. Flick R, Sprung J, Harrison T, et al. Gleich S, Schroeder D, Hanson A,

Buenvenida S, and Warner D. Perioperative cardiac arrests in children between

1988 and 2005 at tertiary referral center. Anesthesiology 2007;106:226–237. .

101. Warner M, Lunn R, O’Leary P, and Schroeder D. Outcomes of noncardiac

surgical procedures in children and adults with congenital heart disease. Mayo

Clinic Proceedings 1998;73:728–734.

102. Hennein H, Mendeloff E, Ciley R, et al.Bove E, and Coran A. Predictors of

postoperative outcome after general surgical procedures in patients with congenital

heart disease. J Pediatr Surg 1994;29:866–870. .

103. Christensen R, Gholami A, Reynolds P, and Malviya S. Anaesthetic management

and outcomes after non-cardiac surgery in patients with hypoplastic left heart

syndrome: a retrospective review. Eur J Anesthesiol 2012;29:425–430.

104. Kipps A, Ramamoorthy C, Rosenthal DN, and Williams G. Children with

cardiomyopathy: complications after noncardiac procedures with general

anesthesia. Pediatr Anesth 2007;17:775–781. . 105. White M. Approach to managing children with heart disease for noncardiac

surgery. Pediatr Anesth 2011;21:522–529. .

106. Lake C. Anesthesia for noncardiac surgery in children with congenital heart

disease. Recista Mexicana de Anestesiologia. 2004;27: Suppl. 1, 63–66. .

107. Dorfman A, Odegard K, Powell A, Laussen P, and Geva T.et al. Risk factors for

adverse events during cardiovascular magnetic resonance in congenital heart

disease. J Cardiovasc Magnetic Resonance 2007;9:793–798. .

108. Jenkins K, Gauvreau K, Newburger J, Spray T, Moller J, and Lezzoni J.et al.

Consensus-based method for risk adjustment for surgery for congenital heart

disease. J Thorac Cardiovasc Surg 2002;123:110–118.

109. Lacour-Gayet F, Clarke D, Jacobs J, Comas J, Daebritz S, Daenen W, Gaynor W,

Hamilton L, Jacobs M, Maruszewski B, Pozzi M, Spray T, Stellin G, Tchervenkow

C, and Mavroudis C.et al. The Aristotle score: a complexity-adjusted method to

evaluate surgical results. Eur J Cardiothorac Surg 2004;26:911–924. .

110. O’ Brien S, Clarke D, Jacobs J , Jacobs M, Lacour-Gayet F, Pizarro C, Welke K,

Maruszewski B, Tabota Z, Miller W, Hamilton L, Peterson E, Mavroudis C, and

Edwards F. et al. An empirically based tool for analyzing mortality associate with

congenital heart surgery. J Thorac Cardiovasc Surg 2009;138:1139–1153.

111. McNew B, Watkins C, and Donahue B. Risks of non-cardiac operations and other

procedures in children with complex congenital heart disease. Society of Pediatric

Anesthesia Spring 2013 Meeting. .

112. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 guidelines on

perioperative cardiovascular evaluation and care for noncardiac surgery: executive

summary: a report of the American College of Cardiology/American Heart

Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac

Surgery). J Am Coll Cardiol 2007;50:1707–32. .

113. Nashef SA, Roques F, Michel P, et al. European system for cardiac operative risk

evaluation. Eur J Cardiothorac Surg 1999;16:9–13.

.

Recommended publications